← ANALYST RATINGS · TIPRANKS
Illumina (ILMN): analyst forecast and price target
Price targets and ratings of
Analyst consensus
Moderate Buy8 Buy3 Hold2 Sell
Ratings of 13 analysts in the last 3 months · top analysts only12-month forecast
$255−2.9% downside
Based on 13 price targets given in the last 3 months, the average target is $255, the highest $320, the lowest $113. The average is −2.9% from the last price of $263.
Highest target $320
Average target $255
Lowest target $113
Analyst ratings 26
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Casey Woodring★★★★★★★★★★#2489 · hits 62% · avg +8.2% | J.P. Morgan | $230 → $320+39.1% | Buy | +21.9% | Reiterated | 16.10.26on TipRanks Oct 17 08:14 | −0.9% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $313 → $310−1.0% | Buy | +18.1% | Reiterated | 14.10.26on TipRanks Oct 13 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $309 → $302−2.3% | Hold | +15.0% | Downgrade | 14.10.26on TipRanks Oct 13 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $303 → $300−1.0% | Hold | +14.3% | Reiterated | 14.10.26on TipRanks Oct 13 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $313 → $310−1.0% | Buy | +18.1% | Reiterated | 14.10.26on TipRanks Oct 13 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $314 → $311−1.0% | Buy | +18.5% | Reiterated | 14.10.26on TipRanks Oct 13 23:05 | — | |
| Daniel Brennan★★★★★★★★★★#271 · hits 58% · avg +21.8% | TD Cowen | $210 → $270+28.6% | Hold | +2.8% | Reiterated | 13.10.26on TipRanks 08:41 | −2.0%next day +1.3% | ↗ |
| Eve Burstein★★★★★★★★★★#1300 · hits 72% · avg +25.0% | Bernstein | $215 | Hold | −18.1% | Reiterated | 12.10.26on TipRanks 06:30 | −0.5%next day −2.0% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $298 → $313+5.0% | Buy | +19.2% | Reiterated | 11.10.26on TipRanks 10:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $294 → $309+5.1% | Buy | +17.7% | Reiterated | 11.10.26on TipRanks 10:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $295 → $310+5.1% | Buy | +18.1% | Reiterated | 11.10.26on TipRanks 10:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $288 → $303+5.2% | Hold | +15.4% | Reiterated | 11.10.26on TipRanks 10:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $298 → $313+5.0% | Buy | +19.2% | Reiterated | 11.10.26on TipRanks 10:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $299 → $314+5.0% | Buy | +19.6% | Reiterated | 11.10.26on TipRanks 10:05 | — | |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | $140 → $168+20.0% | Sell | −36.0% | Reiterated | 09.10.26on TipRanks 08:10 | +4.5%next day −0.5% · 5 days −3.7% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $308 → $298−3.2% | Buy | +13.5% | Reiterated | 09.10.26on TipRanks 01:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $304 → $294−3.3% | Buy | +12.0% | Reiterated | 09.10.26on TipRanks 01:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $305 → $295−3.3% | Buy | +12.4% | Reiterated | 09.10.26on TipRanks 01:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $298 → $288−3.4% | Hold | +9.7% | Reiterated | 09.10.26on TipRanks 01:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $308 → $298−3.2% | Buy | +13.5% | Reiterated | 09.10.26on TipRanks 01:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $309 → $299−3.2% | Buy | +13.9% | Reiterated | 09.10.26on TipRanks 01:05 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $330 → $308−6.7% | Buy | +17.3% | Reiterated | 08.10.26on TipRanks Oct 7 22:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $326 → $304−6.7% | Buy | +15.8% | Reiterated | 08.10.26on TipRanks Oct 7 22:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $327 → $305−6.7% | Buy | +16.2% | Reiterated | 08.10.26on TipRanks Oct 7 22:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $320 → $298−6.9% | Hold | +13.5% | Reiterated | 08.10.26on TipRanks Oct 7 22:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $330 → $308−6.7% | Buy | +17.3% | Reiterated | 08.10.26on TipRanks Oct 7 22:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $332 → $309−6.9% | Buy | +17.7% | Reiterated | 08.10.26on TipRanks Oct 7 22:05 | — | |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $160 → $200+25.0% | Sell | −23.8% | Reiterated | 07.10.26on TipRanks 03:55 | −1.9%next day −0.8% · 5 days +2.5% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $307 → $330+7.5% | Buy | +25.7% | Reiterated | 06.10.26on TipRanks 19:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $303 → $326+7.6% | Buy | +24.2% | Reiterated | 06.10.26on TipRanks 19:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $304 → $327+7.6% | Buy | +24.6% | Reiterated | 06.10.26on TipRanks 19:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $298 → $320+7.4% | Hold | +21.9% | Reiterated | 06.10.26on TipRanks 19:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $307 → $330+7.5% | Buy | +25.7% | Reiterated | 06.10.26on TipRanks 19:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $309 → $332+7.4% | Buy | +26.5% | Reiterated | 06.10.26on TipRanks 19:05 | — | |
| Dan Leonard★★★★★★★★★★#656 · hits 62% · avg +14.1% | RBC Capital | $230 → $310+34.8% | Buy | +18.1% | Reiterated | 04.10.26on TipRanks Oct 5 07:16 | +6.9%next day −7.4% · 5 days −6.2% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $299 → $307+2.7% | Buy | +16.9% | Reiterated | 03.10.26on TipRanks 06:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $295 → $303+2.7% | Buy | +15.4% | Reiterated | 03.10.26on TipRanks 06:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $296 → $304+2.7% | Buy | +15.8% | Reiterated | 03.10.26on TipRanks 06:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $290 → $298+2.8% | Hold | +13.5% | Reiterated | 03.10.26on TipRanks 06:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $299 → $307+2.7% | Buy | +16.9% | Reiterated | 03.10.26on TipRanks 06:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $300 → $309+3.0% | Buy | +17.7% | Reiterated | 03.10.26on TipRanks 06:05 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $308 → $299−2.9% | Buy | +13.9% | Reiterated | 02.10.26on TipRanks 04:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $304 → $295−3.0% | Buy | +12.4% | Reiterated | 02.10.26on TipRanks 04:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $305 → $296−3.0% | Buy | +12.7% | Reiterated | 02.10.26on TipRanks 04:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $298 → $290−2.7% | Hold | +10.5% | Reiterated | 02.10.26on TipRanks 04:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $308 → $299−2.9% | Buy | +13.9% | Reiterated | 02.10.26on TipRanks 04:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $309 → $300−2.9% | Buy | +14.3% | Reiterated | 02.10.26on TipRanks 04:05 | — | |
| Subbu Nambi★★★★★★★★★★#281 · hits 72% · avg +34.4% | Guggenheim | $226 → $305+35.0% | Buy | +16.2% | Reiterated | 01.10.26on TipRanks 08:35 | −3.1%next day +2.0% · 5 days −1.7% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $306 → $308+0.7% | Buy | +17.3% | Reiterated | 01.10.26on TipRanks 03:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $302 → $304+0.7% | Buy | +15.8% | Reiterated | 01.10.26on TipRanks 03:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $303 → $305+0.7% | Buy | +16.2% | Reiterated | 01.10.26on TipRanks 03:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $296 → $298+0.7% | Hold | +13.5% | Reiterated | 01.10.26on TipRanks 03:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $306 → $308+0.7% | Buy | +17.3% | Reiterated | 01.10.26on TipRanks 03:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $307 → $309+0.7% | Buy | +17.7% | Reiterated | 01.10.26on TipRanks 03:05 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $306 | Buy | +16.6% | Reiterated | 30.09.26on TipRanks 03:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $302 | Buy | +15.0% | Reiterated | 30.09.26on TipRanks 03:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $303 | Buy | +15.4% | Reiterated | 30.09.26on TipRanks 03:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $296 | Hold | +12.7% | Reiterated | 30.09.26on TipRanks 03:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $306 | Buy | +16.6% | Reiterated | 30.09.26on TipRanks 03:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $307 | Buy | +16.9% | Reiterated | 30.09.26on TipRanks 03:05 | — | |
| Puneet Souda★★★★★★★★★★#2942 · hits 45% · avg +4.1% | Leerink Partners | $220 → $300+36.4% | Buy | +14.3% | Reiterated | 29.09.26on TipRanks 08:50 | +0.2%next day +0.8% · 5 days −1.4% | ↗ |
| David Westenberg★★★★★★★★★★#602 · hits 56% · avg +17.3% | Piper Sandler | $225 → $305+35.6% | Buy | +16.2% | Assigned | 28.09.26on TipRanks 06:55 | +1.4%next day +0.2% · 5 days +6.8% | ↗ |
| Eve Burstein★★★★★★★★★★#1300 · hits 72% · avg +25.0% | Bernstein | $215 | Hold | −18.1% | Reiterated | 25.09.26on TipRanks Sep 26 08:50 | −2.0%next day +1.4% · 5 days +1.3% | ↗ |
| Daniel Arias★★★★★★★★★★#1848 · hits 50% · avg +8.0% | Stifel Nicolaus | $225 | Buy | −14.3% | Reiterated | 15.09.26on TipRanks 06:30 | +7.2%next day +3.4% · 5 days +9.0% | ↗ |
| Kyle Mikson CFA★★★★★★★★★★#2814 · hits 38% · avg +5.9% | Canaccord Genuity | — | Hold | — | Reiterated | 11.09.26on TipRanks Sep 10 23:30 | +1.7%next day +1.3% · 5 days +16.2% | ↗ |
| Doug Schenkel★★★★★★★★★★#216 · hits 65% · avg +26.2% | Wolfe Research | $135 → $260+92.6% | Buy | −1.0% | Upgrade | 09.09.26on TipRanks Sep 10 23:30 | −2.4%next day −1.2% · 5 days +12.8% | ↗ |
| Jasper Hellweg★★★★★★★★★★#2291 · hits 57% · avg +7.4% | Argus Research | $180 → $235+30.6% | Buy | −10.5% | Reiterated | 02.09.26on TipRanks Sep 3 07:55 | +2.5%next day +2.9% · 5 days −4.7% | ↗ |
| Dan Leonard★★★★★★★★★★#656 · hits 62% · avg +14.1% | RBC Capital | $230 | Buy | −12.4% | Reiterated | 10.08.26on TipRanks Aug 11 06:45 | +2.1%next day +0.9% · 5 days +0.7% | ↗ |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | $140 | Sell | −46.7% | Reiterated | 05.08.26on TipRanks Aug 6 04:55 | −1.3%next day −2.9% · 5 days −3.8% | ↗ |
| Ilya Zubkov★★★★★★★★★★#5009 · hits 59% · avg +9.5% | Freedom Capital Markets | $155 → $185+19.4% | Hold | −29.5% | Downgrade | 05.08.26on TipRanks 09:20 | −1.3%next day −2.9% · 5 days −3.8% | ↗ |
| Casey Woodring★★★★★★★★★★#2489 · hits 62% · avg +8.2% | J.P. Morgan | $230 | Buy | −12.4% | Reiterated | 04.08.26on TipRanks Aug 5 08:08 | +0.6%next day −1.3% · 5 days −4.9% | ↗ |
| Patrick B Donnelly★★★★★★★★★★#2106 · hits 54% · avg +6.0% | Citi | $95.00 → $113+18.9% | Sell | −57.0% | Reiterated | 03.08.26on TipRanks 06:45 | −4.8%next day +0.6% · 5 days −5.2% | ↗ |
| Daniel Brennan★★★★★★★★★★#271 · hits 58% · avg +21.8% | TD Cowen | $192 → $210+9.4% | Hold | −20.0% | Assigned | 31.07.26on TipRanks 06:51 | −0.7%next day −4.8% · 5 days −11.9% | ↗ |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $145 → $160+10.3% | Sell | −39.1% | Reiterated | 31.07.26on TipRanks 05:33 | −0.7%next day −4.8% · 5 days −11.9% | ↗ |
| Subbu Nambi★★★★★★★★★★#281 · hits 72% · avg +34.4% | Guggenheim | $200 → $226+13.0% | Buy | −13.9% | Reiterated | 30.07.26on TipRanks Jul 31 07:00 | +3.6%next day −0.7% · 5 days −9.2% | ↗ |
| Vijay Kumar★★★★★★★★★★#2375 · hits 54% · avg +4.8% | Evercore ISI | $155 → $200+29.0% | Buy | −23.8% | Reiterated | 06.07.26on TipRanks 08:50 | +2.1%next day −0.8% · 5 days −1.9% | ↗ |
| Tycho Peterson★★★★★★★★★★#1097 · hits 57% · avg +9.8% | Jefferies | $150 | Hold | −42.9% | Reiterated | 01.07.26on TipRanks 09:24 | +4.7%next day +2.7% · 5 days +4.6% | ↗ |
| Narumi Nakagiri★★★★★★★★★★#5254 · hits 64% · avg +9.1% | Daiwa | $155 | Buy | −41.0% | Upgrade | 14.05.26on TipRanks 05:15 | −2.0%next day +0.7% · 5 days +1.8% | ↗ |
| Catherine Ramsey Schulte★★★★★★★★★★#864 · hits 53% · avg +11.2% | Robert W. Baird | $132 → $137+3.8% | Hold | −47.8% | Reiterated | 06.02.26on TipRanks 09:55 | −12.3%next day −2.5% · 5 days −1.1% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Illumina
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $221 at a price of $274 (−19.3%); now: $244 at $263 (−7.2%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 5 | 8 | 15 | 15 | 17 | 12 |
| Hold | 6 | 4 | 9 | 8 | 10 | 6 |
| Sell | 6 | 6 | 7 | 5 | 4 | 3 |
Earnings and sales forecast
Next report: 29.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.36 (from $1.33 to $1.38). Last quarter: $1.31.
Sales
Next quarter’s sales estimate — $1.2B (from $1.1B to $1.2B). Last quarter: $1.2B.
Best top-analyst consensus in the sector · Healthcare
About Illumina
- CEO: Jacob Thaysen
- Employees: 8,600
- 5200 Illumina Way, San Diego, CA, 92122, US
- www.illumina.com
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
Data from the stock’s TipRanks forecast page, read 16 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗